the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Anthony Loke: Khazanah has no plan to sell stake in MAHB

KUALA LUMPUR: The Ministry of Transport has brushed off claims that Khazanah Nasional Bhd intends to sell its stake in Malaysia Airports Holdings Bhd (MAHB) to Global Infrastructure Partners (GIP) as reported earlier.

Its Minister, Anthony Loke Siew Fook (pix), said there is no official announcement from Khazanah related to its intention to sell its shareholding in the airport operator.

“No announcement yet from the government to sell to GIP. This matter was never discussed in the Cabinet meeting.

“The equity ownership issue for MAHB to look for strategic (partner) does not involve the Transport Ministry,” he said when winding up the debate on the Motion of Thanks for the Royal Address for his ministry in the Dewan Rakyat, today.

Loke explained that the ministry only functions as a regulator and cannot be involved in the equity restructuring of MAHB, which acts as the operator of the Kuala Lumpur International Airport.

“The equity structure is up to Khazanah, and they will make the decision and will announce if there is any restructuring of the equity holding…it is up to Khazanah. I am confident in Khazanah’s experience and professionalism to assess with whom they want to make as strategic partners,“ he said.

Khazanah is currently the largest shareholder in MAHB with a 32.67 per cent stake, while the Employees Provident Fund (EPF) has a 7.06 per cent equity interest in the airport operator. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings